Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Fenghuang Zhan

Concepts (538)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
128
2024
3049
9.710
Why?
Drug Resistance, Neoplasm
25
2020
309
3.420
Why?
Gene Expression Regulation, Neoplastic
51
2022
868
3.220
Why?
Gene Expression Profiling
40
2023
1141
2.670
Why?
Cell Proliferation
25
2022
1097
2.300
Why?
Antineoplastic Agents
29
2020
1300
2.160
Why?
Cell Line, Tumor
43
2024
1551
1.900
Why?
Plasma Cells
21
2024
239
1.890
Why?
Monoclonal Gammopathy of Undetermined Significance
7
2023
108
1.800
Why?
Neoplastic Stem Cells
7
2020
104
1.770
Why?
Pyrazines
19
2023
203
1.670
Why?
Paraproteinemias
9
2024
80
1.530
Why?
Lymphoma, B-Cell
5
2021
62
1.500
Why?
Boronic Acids
17
2014
197
1.450
Why?
Bone Resorption
6
2024
328
1.420
Why?
Mice
44
2024
6428
1.380
Why?
Apoptosis
17
2022
1302
1.360
Why?
Humans
146
2024
54391
1.250
Why?
Neoplasm Proteins
7
2021
360
1.230
Why?
Osteolysis
4
2022
87
1.180
Why?
Prognosis
36
2024
2126
1.170
Why?
B-Lymphocytes
7
2021
176
1.100
Why?
Animals
53
2024
14409
1.100
Why?
Cell Cycle Proteins
4
2023
198
1.080
Why?
T-Lymphocytes
8
2024
374
1.040
Why?
Ubiquitination
3
2021
47
1.010
Why?
Proteasome Inhibitors
7
2020
111
0.970
Why?
Signal Transduction
21
2023
1752
0.910
Why?
Proteasome Endopeptidase Complex
4
2018
131
0.870
Why?
Hematopoietic Stem Cell Transplantation
5
2024
583
0.870
Why?
MicroRNAs
7
2022
386
0.850
Why?
Antigens, CD
7
2015
242
0.750
Why?
CDC2-CDC28 Kinases
3
2015
15
0.710
Why?
Carrier Proteins
3
2017
360
0.700
Why?
Cation Transport Proteins
2
2019
28
0.690
Why?
Ubiquitins
2
2016
40
0.670
Why?
Cyclin-Dependent Kinases
2
2010
35
0.660
Why?
Glycolysis
3
2022
73
0.660
Why?
Mice, Inbred NOD
5
2020
99
0.660
Why?
Up-Regulation
6
2020
509
0.660
Why?
Disease Progression
17
2023
915
0.660
Why?
Waldenstrom Macroglobulinemia
1
2018
41
0.650
Why?
Proto-Oncogene Proteins c-akt
5
2023
176
0.630
Why?
Chromosome Aberrations
6
2023
316
0.620
Why?
STAT3 Transcription Factor
4
2016
88
0.610
Why?
Pyrimidines
3
2015
196
0.610
Why?
Iron
2
2017
158
0.600
Why?
Pyruvate Kinase
1
2017
8
0.600
Why?
Ascorbic Acid
1
2017
33
0.590
Why?
Cell Survival
10
2020
657
0.590
Why?
RNA Splicing
1
2017
38
0.580
Why?
Oligonucleotide Array Sequence Analysis
17
2014
474
0.580
Why?
Cell Differentiation
8
2023
720
0.570
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1060
0.570
Why?
Cyclopentanes
1
2015
14
0.540
Why?
Down-Regulation
9
2019
388
0.530
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2015
93
0.520
Why?
Thalidomide
10
2023
398
0.520
Why?
Aldehyde Dehydrogenase
1
2014
27
0.510
Why?
Osteoclasts
7
2023
469
0.500
Why?
Dexamethasone
7
2024
435
0.500
Why?
Protein-Tyrosine Kinases
1
2015
101
0.490
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2020
21
0.490
Why?
Hematologic Neoplasms
1
2015
100
0.470
Why?
Receptors, Retinoic Acid
2
2013
27
0.470
Why?
Cystatin M
2
2024
21
0.460
Why?
B-Cell Maturation Antigen
2
2024
72
0.460
Why?
Tumor Microenvironment
5
2024
210
0.450
Why?
Models, Biological
5
2018
825
0.450
Why?
Glucuronidase
4
2018
48
0.430
Why?
Antigens, Neoplasm
6
2014
170
0.430
Why?
Flow Cytometry
8
2018
547
0.430
Why?
Antibodies, Bispecific
2
2023
43
0.420
Why?
Predictive Value of Tests
5
2016
1045
0.400
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.390
Why?
Female
42
2024
28471
0.390
Why?
Arsenicals
1
2010
14
0.390
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
21
0.390
Why?
RNA, Messenger
11
2021
1203
0.390
Why?
Oxides
1
2010
19
0.390
Why?
Immunotherapy, Adoptive
2
2024
134
0.380
Why?
Mice, Transgenic
6
2021
658
0.380
Why?
Janus Kinase 1
1
2010
20
0.370
Why?
Proto-Oncogene Proteins c-jun
2
2009
83
0.370
Why?
MAP Kinase Kinase 1
1
2010
26
0.370
Why?
Male
32
2023
27347
0.370
Why?
Killer Cells, Natural
4
2015
106
0.360
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
101
0.360
Why?
DNA-Binding Proteins
4
2021
462
0.360
Why?
Reverse Transcriptase Polymerase Chain Reaction
11
2015
674
0.360
Why?
Early Growth Response Protein 1
1
2009
39
0.350
Why?
Lymphoma, Large B-Cell, Diffuse
2
2024
106
0.340
Why?
Tretinoin
1
2009
56
0.340
Why?
Oligopeptides
3
2015
95
0.340
Why?
Syndecan-1
5
2017
82
0.340
Why?
Transcription Factors
6
2022
622
0.340
Why?
Xenograft Model Antitumor Assays
7
2019
219
0.330
Why?
Transplantation, Autologous
4
2024
485
0.320
Why?
Osteogenesis
5
2023
377
0.320
Why?
Genes, Neoplasm
1
2008
36
0.320
Why?
NF-kappa B
3
2018
336
0.320
Why?
Tumor Cells, Cultured
6
2020
477
0.320
Why?
Microarray Analysis
3
2018
85
0.310
Why?
Antibodies
3
2024
178
0.310
Why?
S-Phase Kinase-Associated Proteins
1
2007
2
0.300
Why?
Chromosomes, Human, Pair 1
4
2023
113
0.300
Why?
Immunologic Factors
5
2015
130
0.300
Why?
Neoplasms, Plasma Cell
2
2023
39
0.300
Why?
Interleukin-6
3
2019
315
0.300
Why?
Pyrazoles
2
2020
110
0.300
Why?
Tumor Suppressor Protein p53
2
2008
251
0.290
Why?
Small Molecule Libraries
2
2019
72
0.290
Why?
Neoplasms
2
2015
1322
0.290
Why?
Aged
23
2023
10060
0.280
Why?
Mice, SCID
9
2018
196
0.280
Why?
Risk Factors
11
2018
3937
0.260
Why?
Genomics
2
2023
313
0.260
Why?
Survival Rate
8
2020
954
0.250
Why?
Polycomb Repressive Complex 2
2
2021
50
0.250
Why?
Bone Diseases
4
2016
108
0.250
Why?
Enzyme Inhibitors
4
2019
446
0.250
Why?
Ferritins
1
2024
31
0.240
Why?
TNF Receptor-Associated Factor 3
2
2022
14
0.240
Why?
Hydroxybenzoates
1
2024
25
0.240
Why?
Propionates
1
2024
30
0.240
Why?
Myeloid Progenitor Cells
1
2023
19
0.240
Why?
X-Ray Microtomography
1
2024
81
0.240
Why?
Histocompatibility Antigens Class I
2
2015
52
0.240
Why?
Melphalan
3
2023
184
0.230
Why?
Bone Marrow
6
2024
414
0.230
Why?
Middle Aged
22
2021
13082
0.230
Why?
Genes, myc
3
2019
47
0.230
Why?
Intercellular Signaling Peptides and Proteins
4
2007
122
0.230
Why?
Lymphoma
1
2024
72
0.230
Why?
Bone Diseases, Metabolic
1
2024
84
0.220
Why?
Gene Knockdown Techniques
3
2018
125
0.220
Why?
Bone and Bones
2
2021
515
0.220
Why?
NM23 Nucleoside Diphosphate Kinases
1
2022
5
0.220
Why?
Neutropenia
1
2023
120
0.220
Why?
Periodontitis
1
2022
10
0.220
Why?
Recurrence
7
2018
692
0.220
Why?
Phenols
1
2024
122
0.220
Why?
Randomized Controlled Trials as Topic
6
2016
594
0.210
Why?
Protein Binding
2
2018
736
0.210
Why?
Case-Control Studies
8
2020
1229
0.210
Why?
Protein Stability
2
2020
44
0.210
Why?
Reactive Oxygen Species
4
2017
491
0.210
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
164
0.210
Why?
Kaplan-Meier Estimate
5
2016
514
0.200
Why?
Heterogeneous-Nuclear Ribonucleoprotein Group A-B
1
2021
1
0.200
Why?
Nuclear Factor 90 Proteins
1
2021
1
0.200
Why?
Osteoporosis
1
2023
164
0.200
Why?
Ubiquitin-Protein Ligases
2
2020
100
0.200
Why?
Arthritis, Rheumatoid
1
2022
130
0.200
Why?
Antibodies, Monoclonal
3
2013
564
0.200
Why?
RANK Ligand
1
2022
183
0.200
Why?
In Situ Hybridization, Fluorescence
4
2023
278
0.200
Why?
Hippurates
1
2021
10
0.200
Why?
Phenylpropionates
1
2021
13
0.200
Why?
Venous Thromboembolism
3
2011
75
0.200
Why?
Proteolysis
3
2017
102
0.190
Why?
Bone Neoplasms
2
2015
193
0.190
Why?
Adaptor Proteins, Signal Transducing
1
2021
208
0.190
Why?
Colorectal Neoplasms
2
2022
237
0.190
Why?
Antigens, CD20
2
2014
4
0.190
Why?
Protease Inhibitors
3
2011
64
0.190
Why?
Colonic Neoplasms
1
2022
164
0.190
Why?
Cell Cycle
4
2010
275
0.190
Why?
Receptors, G-Protein-Coupled
1
2021
55
0.190
Why?
Cell Movement
2
2015
271
0.190
Why?
Membrane Proteins
3
2017
389
0.190
Why?
Neoplasm Metastasis
4
2015
252
0.190
Why?
Chromosomal Instability
3
2021
17
0.190
Why?
Evolution, Molecular
1
2021
103
0.180
Why?
Disease-Free Survival
7
2016
488
0.180
Why?
Cytotoxicity, Immunologic
4
2015
62
0.180
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2015
70
0.180
Why?
Retrospective Studies
7
2024
6459
0.180
Why?
Oxidative Stress
4
2016
958
0.180
Why?
Treatment Outcome
12
2020
5612
0.180
Why?
Antigens, CD19
2
2018
19
0.180
Why?
Bone Marrow Cells
3
2015
232
0.180
Why?
Membrane Glycoproteins
5
2009
270
0.180
Why?
Gene Expression
3
2017
664
0.180
Why?
Adult
19
2021
14207
0.180
Why?
Neoplasm Recurrence, Local
1
2024
645
0.180
Why?
Tumor Suppressor Proteins
2
2019
141
0.180
Why?
Time Factors
8
2021
3210
0.180
Why?
Clinical Trials as Topic
1
2022
491
0.180
Why?
DNA, Single-Stranded
1
2020
73
0.170
Why?
Oncogene Proteins
1
2019
17
0.170
Why?
Cluster Analysis
4
2009
249
0.170
Why?
Transplantation, Heterologous
2
2017
76
0.170
Why?
Healthcare Disparities
1
2022
269
0.170
Why?
NF-E2-Related Factor 2
1
2019
63
0.170
Why?
Carcinoma, Neuroendocrine
1
2019
27
0.170
Why?
Mitosis
3
2015
106
0.170
Why?
rab GTP-Binding Proteins
1
2019
39
0.170
Why?
Receptors, Interleukin-6
1
2018
29
0.170
Why?
Proto-Oncogene Proteins c-myc
2
2017
55
0.170
Why?
Drug Tolerance
1
2018
60
0.170
Why?
Pyridines
1
2019
137
0.160
Why?
Neovascularization, Pathologic
3
2009
168
0.160
Why?
Blotting, Western
3
2015
684
0.160
Why?
Lung Neoplasms
1
2024
643
0.160
Why?
Drug Therapy, Combination
2
2017
426
0.150
Why?
beta Catenin
2
2015
102
0.150
Why?
M Phase Cell Cycle Checkpoints
1
2017
4
0.150
Why?
Mice, Knockout
4
2023
927
0.150
Why?
Aerobiosis
1
2017
16
0.150
Why?
Hydroxamic Acids
2
2014
47
0.150
Why?
Microfilament Proteins
1
2017
47
0.150
Why?
Thyroid Hormones
1
2017
18
0.150
Why?
Onium Compounds
1
2016
14
0.150
Why?
Calcium-Binding Proteins
1
2017
61
0.150
Why?
Deoxyglucose
1
2016
37
0.150
Why?
Organophosphorus Compounds
1
2016
17
0.150
Why?
Histone Deacetylase Inhibitors
2
2014
56
0.150
Why?
Inhibitor of Apoptosis Proteins
3
2015
21
0.140
Why?
Survival Analysis
6
2020
736
0.140
Why?
RNA Interference
2
2015
195
0.140
Why?
Gene Deletion
2
2008
293
0.140
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2016
48
0.140
Why?
Pancreatic Neoplasms
1
2019
234
0.140
Why?
Ribosomal Proteins
1
2016
32
0.140
Why?
Cell Death
1
2016
223
0.140
Why?
Oncolytic Virotherapy
1
2015
18
0.140
Why?
Aged, 80 and over
7
2021
3431
0.140
Why?
Proto-Oncogene Proteins
2
2009
169
0.140
Why?
Macrophages
2
2022
404
0.130
Why?
Cell Adhesion Molecules
1
2015
87
0.130
Why?
Gene Dosage
2
2013
92
0.130
Why?
Polysaccharides
1
2015
57
0.130
Why?
Core Binding Factor Alpha 1 Subunit
1
2015
48
0.130
Why?
Receptors, Transferrin
1
2015
17
0.130
Why?
Side-Population Cells
1
2015
3
0.130
Why?
Lentivirus
1
2015
18
0.130
Why?
Retinal Dehydrogenase
1
2014
10
0.130
Why?
Serine Endopeptidases
2
2006
57
0.130
Why?
Receptors, Cell Surface
1
2015
130
0.130
Why?
Adenine
1
2015
44
0.130
Why?
Caspase 3
2
2022
135
0.130
Why?
Cell Lineage
1
2014
93
0.120
Why?
Serum
1
2014
39
0.120
Why?
Proto-Oncogene Proteins c-kit
1
2014
35
0.120
Why?
Superoxide Dismutase
1
2014
125
0.120
Why?
Piperidines
1
2015
103
0.120
Why?
Tumor Burden
3
2020
141
0.120
Why?
Cyclins
3
2015
54
0.120
Why?
HLA Antigens
1
2014
56
0.120
Why?
Alkaline Phosphatase
2
2011
99
0.120
Why?
Glycoproteins
1
2014
132
0.120
Why?
11-beta-Hydroxysteroid Dehydrogenase Type 2
1
2013
12
0.120
Why?
Leukemia, Plasma Cell
1
2013
34
0.120
Why?
Repressor Proteins
4
2015
165
0.120
Why?
Lactate Dehydrogenases
1
2013
2
0.120
Why?
Intercellular Adhesion Molecule-1
1
2013
75
0.110
Why?
Genome, Human
2
2021
131
0.110
Why?
Phenotype
4
2009
819
0.110
Why?
Scavenger Receptors, Class A
1
2013
38
0.110
Why?
Leukemia
1
2013
69
0.110
Why?
bcl-X Protein
1
2013
61
0.110
Why?
Heat-Shock Proteins
1
2013
87
0.110
Why?
Follow-Up Studies
5
2024
2390
0.110
Why?
Dose-Response Relationship, Drug
4
2020
1476
0.110
Why?
RNA, Neoplasm
3
2007
54
0.110
Why?
Clinical Trials, Phase III as Topic
2
2012
48
0.110
Why?
Disease Models, Animal
4
2020
1647
0.100
Why?
RNA, Small Interfering
2
2010
253
0.100
Why?
Forkhead Transcription Factors
2
2023
118
0.100
Why?
Cysteine Proteinase Inhibitors
1
2011
28
0.100
Why?
Drug Screening Assays, Antitumor
3
2020
142
0.100
Why?
Activated Protein C Resistance
1
2011
10
0.100
Why?
Factor V
1
2011
11
0.100
Why?
Protein Isoforms
2
2009
124
0.100
Why?
Glucocorticoids
1
2013
234
0.100
Why?
Acetylcysteine
1
2011
118
0.100
Why?
Interferon Regulatory Factor-1
1
2010
14
0.100
Why?
Cell Growth Processes
1
2010
24
0.100
Why?
HLA-A Antigens
2
2007
13
0.100
Why?
Gene Silencing
2
2007
129
0.090
Why?
Alleles
2
2021
277
0.090
Why?
Thrombosis
1
2012
243
0.090
Why?
Immunophenotyping
5
2010
117
0.090
Why?
Cells, Cultured
6
2015
1737
0.090
Why?
Epigenesis, Genetic
2
2023
399
0.090
Why?
K562 Cells
3
2016
47
0.090
Why?
Microtubule-Associated Proteins
1
2009
78
0.090
Why?
Syndecans
2
2006
43
0.090
Why?
Chromosome Mapping
2
2006
175
0.090
Why?
Bone Remodeling
1
2010
176
0.090
Why?
Thromboembolism
1
2009
56
0.080
Why?
Recombinant Proteins
1
2010
570
0.080
Why?
Proteoglycans
2
2006
96
0.080
Why?
Lymphocyte Subsets
1
2008
13
0.080
Why?
Neoplasm Staging
3
2024
805
0.080
Why?
Receptors, Immunologic
1
2008
37
0.080
Why?
ras Proteins
2
2020
70
0.080
Why?
Neoplasm Transplantation
2
2020
94
0.080
Why?
G2 Phase Cell Cycle Checkpoints
2
2020
7
0.080
Why?
Genes, abl
1
2007
1
0.080
Why?
Adoptive Transfer
1
2007
38
0.080
Why?
Protein Tyrosine Phosphatases
1
2007
29
0.080
Why?
Angiogenesis Inhibitors
1
2009
203
0.080
Why?
Patient Selection
1
2009
284
0.080
Why?
Mutation
3
2021
1504
0.080
Why?
Breast Neoplasms
2
2007
1249
0.080
Why?
HEK293 Cells
2
2019
245
0.070
Why?
JNK Mitogen-Activated Protein Kinases
1
2007
78
0.070
Why?
Translocation, Genetic
3
2021
287
0.070
Why?
Cyclin D
1
2006
20
0.070
Why?
Cancer Vaccines
1
2007
103
0.070
Why?
Chromosome Banding
1
2006
28
0.070
Why?
Drug Evaluation, Preclinical
2
2021
158
0.070
Why?
Caspases
1
2007
146
0.070
Why?
Proportional Hazards Models
2
2024
430
0.070
Why?
Maf Transcription Factors, Large
1
2005
1
0.070
Why?
Models, Genetic
1
2006
209
0.070
Why?
DNA Damage
1
2008
357
0.070
Why?
Peptides
1
2007
276
0.070
Why?
Gene Expression Regulation, Enzymologic
1
2007
206
0.070
Why?
Doxorubicin
2
2018
259
0.070
Why?
Data Interpretation, Statistical
1
2006
177
0.070
Why?
Cyclin D1
1
2005
60
0.060
Why?
Protein Kinases
1
2005
88
0.060
Why?
Antibody Formation
1
2005
69
0.060
Why?
Protein Biosynthesis
2
2003
273
0.060
Why?
Papillomaviridae
1
2005
107
0.060
Why?
Cystadenocarcinoma, Serous
1
2004
74
0.060
Why?
Mice, Inbred C57BL
2
2021
2001
0.060
Why?
Carcinoma, Papillary
1
2004
65
0.060
Why?
Transfection
2
2020
399
0.060
Why?
Base Sequence
3
2015
719
0.060
Why?
Drug Synergism
2
2014
171
0.060
Why?
Jurkat Cells
2
2014
34
0.060
Why?
Mice, Inbred BALB C
2
2019
370
0.060
Why?
Zebrafish Proteins
1
2003
23
0.060
Why?
Extracellular Matrix Proteins
1
2004
75
0.060
Why?
Transcription, Genetic
1
2005
418
0.060
Why?
Adipogenesis
1
2024
54
0.060
Why?
Steroids
1
2024
55
0.060
Why?
Ovariectomy
1
2024
127
0.060
Why?
Genetic Predisposition to Disease
1
2007
570
0.060
Why?
Sequence Analysis, RNA
1
2024
107
0.060
Why?
PPAR gamma
1
2024
81
0.060
Why?
Integrin beta Chains
1
2023
14
0.060
Why?
Integrins
1
2023
36
0.060
Why?
Chromosomes, Human, Pair 13
1
2003
41
0.060
Why?
Oxidative Phosphorylation
1
2023
57
0.060
Why?
Cytogenetic Analysis
1
2023
90
0.060
Why?
Porphyromonas gingivalis
1
2022
3
0.060
Why?
Macrophage Activation
1
2022
29
0.050
Why?
Chromosome Deletion
1
2023
150
0.050
Why?
Geography
1
2022
80
0.050
Why?
Protein Kinase Inhibitors
2
2014
216
0.050
Why?
Chromatin
1
2023
156
0.050
Why?
Uterine Cervical Neoplasms
1
2005
276
0.050
Why?
Inflammasomes
1
2022
60
0.050
Why?
Diploidy
3
2007
30
0.050
Why?
DNA, Neoplasm
1
2002
171
0.050
Why?
Models, Animal
2
2015
255
0.050
Why?
Mutation Rate
1
2021
40
0.050
Why?
DNA Primers
2
2015
225
0.050
Why?
Clone Cells
1
2021
89
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
70
0.050
Why?
Genes, Tumor Suppressor
1
2021
85
0.050
Why?
HCT116 Cells
1
2020
27
0.050
Why?
Proteins
1
2003
376
0.050
Why?
DNA Copy Number Variations
1
2021
114
0.050
Why?
Wnt Signaling Pathway
1
2021
94
0.050
Why?
3' Untranslated Regions
1
2020
57
0.050
Why?
Double-Blind Method
2
2014
743
0.050
Why?
Ovarian Neoplasms
1
2004
474
0.050
Why?
Cytokines
3
2009
677
0.050
Why?
Gene Knockout Techniques
1
2019
45
0.040
Why?
Immunohistochemistry
3
2009
1090
0.040
Why?
Drug Discovery
1
2020
90
0.040
Why?
Protein Phosphatase 2
1
2019
6
0.040
Why?
Crystallography, X-Ray
1
2019
178
0.040
Why?
Enzyme Activators
1
2019
8
0.040
Why?
G1 Phase
1
2019
19
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
15
0.040
Why?
Genetic Variation
1
2020
253
0.040
Why?
DNA
1
2023
581
0.040
Why?
Protein Conformation
1
2019
226
0.040
Why?
Mice, Nude
1
2019
284
0.040
Why?
Multivariate Analysis
1
2021
643
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
206
0.040
Why?
Structure-Activity Relationship
1
2020
423
0.040
Why?
Immunotherapy
1
2021
264
0.040
Why?
Wnt Proteins
2
2013
110
0.040
Why?
Computational Biology
1
2020
231
0.040
Why?
TOR Serine-Threonine Kinases
1
2019
85
0.040
Why?
Drug Resistance
1
2018
75
0.040
Why?
DNA Methylation
1
2023
575
0.040
Why?
Phosphorylation
1
2020
613
0.040
Why?
Autophagy
1
2020
202
0.040
Why?
Cell Cycle Checkpoints
1
2017
35
0.040
Why?
Gene Expression Regulation
1
2022
1063
0.040
Why?
Cross-Sectional Studies
1
2022
1696
0.040
Why?
CD8-Positive T-Lymphocytes
2
2007
116
0.040
Why?
Endoplasmic Reticulum Stress
1
2016
42
0.040
Why?
Cell Hypoxia
1
2016
87
0.040
Why?
Biological Transport
1
2016
195
0.040
Why?
Mice, Inbred ICR
1
2016
25
0.030
Why?
Drug Interactions
1
2016
206
0.030
Why?
Chronic Disease
1
2019
614
0.030
Why?
Models, Statistical
2
2008
259
0.030
Why?
Microscopy, Electron, Transmission
1
2015
87
0.030
Why?
Mitoxantrone
1
2015
11
0.030
Why?
Transcriptional Activation
1
2016
134
0.030
Why?
Vidarabine
1
2015
12
0.030
Why?
Reoviridae
1
2015
28
0.030
Why?
Pharmacogenetics
2
2006
55
0.030
Why?
Cell Line
2
2013
1152
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2015
55
0.030
Why?
China
1
2015
104
0.030
Why?
Vincristine
1
2015
98
0.030
Why?
Vaccination
2
2007
298
0.030
Why?
Prednisone
1
2015
111
0.030
Why?
Ligands
1
2015
229
0.030
Why?
Disulfiram
1
2014
11
0.030
Why?
Glutathione Peroxidase
1
2014
28
0.030
Why?
Molecular Targeted Therapy
1
2016
128
0.030
Why?
Cyclin B
1
2014
6
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cyclophosphamide
1
2015
172
0.030
Why?
CDC2 Protein Kinase
1
2014
23
0.030
Why?
Microscopy, Fluorescence
1
2015
198
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
48
0.030
Why?
Risk Assessment
2
2009
1362
0.030
Why?
Glucose
1
2016
366
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
1
2013
12
0.030
Why?
Chemotherapy, Adjuvant
1
2014
119
0.030
Why?
Lectins, C-Type
1
2013
32
0.030
Why?
Veratrum Alkaloids
1
2013
5
0.030
Why?
Multidrug Resistance-Associated Proteins
1
2013
19
0.030
Why?
Isoxazoles
1
2013
16
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2013
21
0.030
Why?
Gene Expression Regulation, Leukemic
1
2013
36
0.030
Why?
Sulfones
1
2013
24
0.030
Why?
Hedgehog Proteins
1
2013
33
0.030
Why?
Itraconazole
1
2013
45
0.030
Why?
Peptide Library
1
2013
29
0.030
Why?
Receptors, Glucocorticoid
1
2013
36
0.030
Why?
Glutathione
1
2014
330
0.030
Why?
Receptors, IgG
1
2013
22
0.030
Why?
Azacitidine
1
2013
37
0.030
Why?
ADP-ribosyl Cyclase
2
2003
5
0.030
Why?
Oxidants
1
2013
64
0.030
Why?
Hydrocortisone
1
2013
124
0.030
Why?
p38 Mitogen-Activated Protein Kinases
1
2013
99
0.030
Why?
Epitopes
1
2013
89
0.030
Why?
Histone Deacetylases
1
2013
47
0.030
Why?
MAP Kinase Signaling System
1
2013
133
0.030
Why?
Hydrogen Peroxide
1
2013
142
0.030
Why?
Prospective Studies
2
2010
2606
0.030
Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
158
0.030
Why?
Radiation, Ionizing
1
2013
120
0.030
Why?
Clinical Trials, Phase II as Topic
1
2012
51
0.030
Why?
Osteoblasts
2
2006
514
0.030
Why?
Transcriptome
1
2014
346
0.030
Why?
Viper Venoms
1
2011
7
0.030
Why?
Protein C
1
2011
23
0.030
Why?
Risk
1
2011
343
0.020
Why?
Bone Density Conservation Agents
1
2010
82
0.020
Why?
Databases as Topic
1
2009
46
0.020
Why?
Diphosphonates
1
2010
96
0.020
Why?
Lymphocytes
1
2010
168
0.020
Why?
Parathyroid Hormone
1
2010
196
0.020
Why?
Cytoskeleton
1
2008
50
0.020
Why?
STAT Transcription Factors
1
2007
7
0.020
Why?
Twins
1
2007
32
0.020
Why?
Cytological Techniques
1
2007
15
0.020
Why?
NF-kappa B p52 Subunit
1
2007
6
0.020
Why?
Genotype
1
2009
600
0.020
Why?
NF-kappa B p50 Subunit
1
2007
16
0.020
Why?
I-kappa B Kinase
1
2007
29
0.020
Why?
HLA-A2 Antigen
1
2007
12
0.020
Why?
Karyotyping
1
2007
92
0.020
Why?
T-Lymphocytes, Cytotoxic
1
2007
72
0.020
Why?
Antigen Presentation
1
2007
28
0.020
Why?
Benzamides
1
2007
54
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2009
240
0.020
Why?
Polysaccharide-Lyases
1
2007
6
0.020
Why?
Remission Induction
1
2007
222
0.020
Why?
Leukocytes, Mononuclear
1
2007
133
0.020
Why?
Plasmids
1
2007
180
0.020
Why?
Tissue Culture Techniques
1
2007
46
0.020
Why?
Multigene Family
1
2006
54
0.020
Why?
Interferon-gamma
1
2007
195
0.020
Why?
Enzyme Activation
1
2007
328
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2007
314
0.020
Why?
Antineoplastic Agents, Hormonal
1
2006
49
0.020
Why?
Piperazines
1
2007
115
0.020
Why?
Neoplasms, Experimental
1
2007
115
0.020
Why?
Anticoagulants
1
2009
270
0.020
Why?
Dendritic Cells
1
2007
142
0.020
Why?
Receptors, Estrogen
1
2007
131
0.020
Why?
Chromosomes, Human
1
2006
45
0.020
Why?
Gelatinases
1
2006
36
0.020
Why?
Incidence
1
2009
1083
0.020
Why?
Diagnosis, Differential
1
2010
1141
0.020
Why?
Endopeptidases
1
2006
75
0.020
Why?
Coculture Techniques
1
2006
159
0.020
Why?
Polymerase Chain Reaction
1
2007
531
0.020
Why?
Rabbits
1
2006
425
0.020
Why?
Combined Modality Therapy
1
2007
693
0.020
Why?
Cyclin D3
1
2005
6
0.020
Why?
Cyclin D2
1
2005
20
0.020
Why?
Trisomy
1
2005
34
0.020
Why?
Adipocytes
1
2006
128
0.020
Why?
Oligonucleotide Probes
1
2004
21
0.020
Why?
Epithelium
1
2004
68
0.020
Why?
Stem Cells
1
2006
194
0.020
Why?
Ovary
1
2004
105
0.020
Why?
Molecular Sequence Data
1
2006
980
0.020
Why?
Endothelium, Vascular
1
2006
288
0.020
Why?
Endothelial Cells
1
2006
294
0.010
Why?
Palatine Tonsil
1
2003
12
0.010
Why?
Databases, Factual
1
2007
683
0.010
Why?
RNA, Complementary
1
2003
4
0.010
Why?
Autocrine Communication
1
2003
10
0.010
Why?
Paracrine Communication
1
2003
12
0.010
Why?
Metaphase
1
2003
55
0.010
Why?
Melanoma-Specific Antigens
1
2002
3
0.010
Why?
NAD+ Nucleosidase
1
2002
3
0.010
Why?
Bacterial Proteins
1
2007
456
0.010
Why?
Cell Separation
1
2003
107
0.010
Why?
Cell Communication
1
2003
72
0.010
Why?
Antigens, Differentiation
1
2002
23
0.010
Why?
Gene Expression Regulation, Developmental
1
2003
151
0.010
Why?
Biopsy
1
2005
692
0.010
Why?
Cohort Studies
1
2006
1546
0.010
Why?
Immunoglobulins
1
2002
89
0.010
Why?
Reproducibility of Results
1
2005
1301
0.010
Why?
Logistic Models
1
2003
991
0.010
Why?
Magnetic Resonance Imaging
1
2003
1616
0.010
Why?
Zhan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description